Copper is a Potent Inhibitor of Both the Canonical and Non-canonical NFκB Pathways

Overview

Journal Cell Cycle

Specialty Cell Biology

Date 2014 Feb 21

PMID 24552822

Citations 11

Authors

Niall S Kenneth

George E Hucks Jr

Andrew J Kocab

Annie L McCollom

Colin S Duckett

Affiliations

Soon will be listed here.

Abstract

Copper is an essential trace element that plays key roles in many metabolic processes. Homeostatic regulation of intracellular copper is normally tightly controlled, but deregulated copper levels are found in numerous metabolic and neurodegenerative diseases, as well as in a range of neoplasms. There are conflicting reports regarding the exact role of copper in the regulation of NFκB-responsive genes, specifically whether copper leads to increased activation of the NFκB pathways, or downregulation. Here we show that increased intracellular levels of copper, using the ionophore clioquinol, leads to a potent inhibition of NFκB pathways, induced by multiple distinct stimuli. Addition of copper to cells inhibits ubiquitin-mediated degradation of IκBα by preventing its phoshorylation by the upstream IKK complex. Intriguingly, copper-dependent inhibition of NFκB can be reversed by the addition of the reducing agent, N-acetylcysteine (NAC). These results suggest that the oxidative properties of excess copper prevent NFκB activation by blocking IκBα destruction, and that NFκB activity should be assessed in diseases associated with copper excess.

Citing Articles

Copper homeostasis dysregulation in respiratory diseases: a review of current knowledge.

Song W, Yue Y, Zhang Q, Wang X Front Physiol. 2024; 15:1243629.

PMID: 38883186 PMC: 11176810. DOI: 10.3389/fphys.2024.1243629.

The p53 protein is a suppressor of Atox1 copper chaperon in tumor cells under genotoxic effects.

Tsymbal S, Refeld A, Zatsepin V, Kuchur O PLoS One. 2023; 18(12):e0295944.

PMID: 38127999 PMC: 10735018. DOI: 10.1371/journal.pone.0295944.

A Novel Vision of Reinforcing Nanofibrous Masks with Metal Nanoparticles: Antiviral Mechanisms Investigation.

Hadinejad F, Morad H, Jahanshahi M, Zarrabi A, Pazoki-Toroudi H, Mostafavi E Adv Fiber Mater. 2023; :1-45.

PMID: 37361103 PMC: 10088653. DOI: 10.1007/s42765-023-00275-7.

Chrysin Encapsulated Copper Nanoparticles with Low Dose of Gamma Radiation Elicit Tumor Cell Death Through p38 MAPK/NF-κB Pathways.

Abdelhakm L, Kandil E, Mansour S, El-Sonbaty S Biol Trace Elem Res. 2023; 201(11):5278-5297.

PMID: 36905557 PMC: 10509080. DOI: 10.1007/s12011-023-03596-1.

Identification of biomarkers related to copper metabolism in patients with pulmonary arterial hypertension.

Wang L, Zhang W, Li C, Chen X, Huang J BMC Pulm Med. 2023; 23(1):31.

PMID: 36690956 PMC: 9868507. DOI: 10.1186/s12890-023-02326-6.

References

Rotilio G, Carri M, Rossi L, Ciriolo M . Copper-dependent oxidative stress and neurodegeneration. IUBMB Life. 2001; 50(4-5):309-14. DOI: 10.1080/713803724. View

Perkins N . The diverse and complex roles of NF-κB subunits in cancer. Nat Rev Cancer. 2012; 12(2):121-32. DOI: 10.1038/nrc3204. View

Goodman V, Brewer G, Merajver S . Copper deficiency as an anti-cancer strategy. Endocr Relat Cancer. 2004; 11(2):255-63. DOI: 10.1677/erc.0.0110255. View

Mao X, Li X, Sprangers R, Wang X, Venugopal A, Wood T . Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma. Leukemia. 2008; 23(3):585-90. DOI: 10.1038/leu.2008.232. View

Formigari A, Gregianin E, Irato P . The effect of zinc and the role of p53 in copper-induced cellular stress responses. J Appl Toxicol. 2013; 33(7):527-36. DOI: 10.1002/jat.2854. View

Hayden M, Ghosh S . Shared principles in NF-kappaB signaling. Cell. 2008; 132(3):344-62. DOI: 10.1016/j.cell.2008.01.020. View

Cater M, Haupt Y . Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer. Biochem J. 2011; 436(2):481-91. DOI: 10.1042/BJ20110123. View

Tisato F, Marzano C, Porchia M, Pellei M, Santini C . Copper in diseases and treatments, and copper-based anticancer strategies. Med Res Rev. 2009; 30(4):708-49. DOI: 10.1002/med.20174. View

DiDonato J, Mercurio F, Karin M . Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B. Mol Cell Biol. 1995; 15(3):1302-11. PMC: 230353. DOI: 10.1128/MCB.15.3.1302. View

10.

Kim B, Nevitt T, Thiele D . Mechanisms for copper acquisition, distribution and regulation. Nat Chem Biol. 2008; 4(3):176-85. DOI: 10.1038/nchembio.72. View

11.

Zhai S, Yang L, Cui Q, Sun Y, Dou Q, Yan B . Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells. J Biol Inorg Chem. 2009; 15(2):259-69. PMC: 2814311. DOI: 10.1007/s00775-009-0594-5. View

12.

Chen D, Cui Q, Yang H, Dou Q . Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res. 2006; 66(21):10425-33. DOI: 10.1158/0008-5472.CAN-06-2126. View

13.

Schimmer A, Jitkova Y, Gronda M, Wang Z, Brandwein J, Chen C . A phase I study of the metal ionophore clioquinol in patients with advanced hematologic malignancies. Clin Lymphoma Myeloma Leuk. 2012; 12(5):330-6. DOI: 10.1016/j.clml.2012.05.005. View

14.

Ramakrishnan P, Baltimore D . Sam68 is required for both NF-κB activation and apoptosis signaling by the TNF receptor. Mol Cell. 2011; 43(2):167-79. PMC: 3142289. DOI: 10.1016/j.molcel.2011.05.007. View

15.

Pineda-Molina E, Klatt P, Vazquez J, Marina A, Garcia de Lacoba M, Perez-Sala D . Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry. 2001; 40(47):14134-42. DOI: 10.1021/bi011459o. View

16.

Chen D, Cui Q, Yang H, Barrea R, Sarkar F, Sheng S . Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts. Cancer Res. 2007; 67(4):1636-44. DOI: 10.1158/0008-5472.CAN-06-3546. View

17.

Khan G, Merajver S . Copper chelation in cancer therapy using tetrathiomolybdate: an evolving paradigm. Expert Opin Investig Drugs. 2009; 18(4):541-8. DOI: 10.1517/13543780902845622. View

18.

White A, Du T, Laughton K, Volitakis I, Sharples R, Xilinas M . Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity. J Biol Chem. 2006; 281(26):17670-80. DOI: 10.1074/jbc.M602487200. View

19.

Rumble J, Bertrand M, Csomos R, Wright C, Albert L, Mak T . Apoptotic sensitivity of murine IAP-deficient cells. Biochem J. 2008; 415(1):21-5. PMC: 2676106. DOI: 10.1042/BJ20081188. View

20.

Ghosh S, Hayden M . Celebrating 25 years of NF-κB research. Immunol Rev. 2012; 246(1):5-13. PMC: 3313446. DOI: 10.1111/j.1600-065X.2012.01111.x. View